SRC and breast carcinoma: FAK aggravates cancer progression by activating the Src, PI3K-Akt, and Raf-MEK-ERK signaling pathways [26], and the deletion of FAK in mammary epithelial cells suppresses tumor formation and progression in mouse models of breast cancer [27,28,29].